• Articles
• Presentations
• Events/Seminars
• IP Alerts
• Q&A Booklets
• In the News
• Press Releases
• IP Case Law Analysis
• IP Outlook Newsletter
• RSS Feeds

“Cephalon settlement with generic makers in Nuvigil patent suits could be delayed by ongoing antitrust litigation - experts”

Hunter Baker was quoted in an article in Pharmawire entitled “Cephalon settlement with generic makers in Nuvigil patent suits could be delayed by ongoing antitrust litigation - experts”